Skip to main content
Premium Trial:

Request an Annual Quote

Strong Sales in Invitrogen s BioDiscovery Unit Spurred 30-Percent Revenue Growth

NEW YORK, Oct. 29 (GenomeWeb News) - Invitrogen today reported strong sales in its BioDiscovery business unit helped propel a 30-percent spike in third-quarter revenue atop a widened profit and R&D spending.


Total receipts for the three months ended Sept. 30 increased to 256.3 million from $197 million one year ago. Invitrogen said BioDiscovery grew 17 percent year over year, while BioProduction surged 53 percent.


R&D spending also increased in the third quarter, to $19.2 million from $15.4 million year over year.


Net income jumped to $28.7 million, or $.54 per basic share, from $13.7 million, or $.27 per basic share, one year ago.


Invitrogen said it had around $939.8 million in cash and investments as of Sept. 30.


The company reiterated its 2004 revenue forecast of around $1 billion.


As GenomeWeb News reported yesterday, Invitrogen acquired DNA Research Innovations of Kent, UK, for $30 million in cash and $30 million in milestone payments.


Privately held DNA Research Innovation develops and sells ChargeSwitch technology, a DNA/RNA purification technology.


The acquisition follows Invitrogen's purchase of Protometrix in April; Xeotron in May; and Molecular Probes in August.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.